The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Volume 328:373-379 February 11, 1993 Number 6
NextNext

Unexplained Opportunistic Infections and CD4+ T-Lymphocytopenia without HIV Infection -- An Investigation of Cases in the United States
Dawn K. Smith, Joyce J. Neal, Scott D. Holmberg, for The Centers for Disease Control Idiopathic CD4+ T-Lymphocytopenia Task Force

 Sign up for free e-toc
 

This Article
-Full Text

Commentary
-Letters
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background The clinical and public health importance of recent reports of patients with CD4+ T-lymphocytopenia without human immunodeficiency virus (HIV) infection is unclear. We conducted investigations to determine the demographic, clinical, and immunologic features of patients with idiopathic CD4+ T-lymphocytopenia; whether the syndrome is epidemic or transmissible; and the possible causes.

Methods We reviewed 230,179 cases in the Centers for Disease Control and Prevention (CDC) AIDS Reporting System and performed interviews, medical-record reviews, and laboratory analyses of blood specimens from adults and adolescents who met the CDC case definition of idiopathic CD4+ T-lymphocytopenia (<300 CD4+ cells per cubic millimeter or a CD4+ cell count <20 percent of total T cells on two occasions and no evidence of infection on HIV testing), their sexual contacts, household contacts, and persons who had donated blood to them.

Results We interviewed 31 of the 47 patients identified with idiopathic CD4+ T-lymphocytopenia and 23 of their contacts. There were 29 male and 18 female patients, with a mean age of 43 years (range, 17 to 78); 39 were white, 4 were Asian, 2 were Hispanic, and 2 were black. Eighteen patients (38 percent) had one or more risk factors for HIV infection: seven had hemophilia, six had engaged in homosexual sex, six had received blood transfusions, and two had had heterosexual sex partners who were at risk for HIV infection. The other 29 patients (62 percent) had no identified risk factors for HIV infection. Nineteen persons (40 percent) had AIDS-defining illnesses (18 had opportunistic infections), 25 (53 percent) had conditions that were not AIDS-defining, and 3 (6 percent) were asymptomatic. We tested blood from 28 patients: 8 (29 percent) were found to have CD4+ T-lymphocyte counts of less than 300 cells per cubic millimeter, and 6 had CD8+ T-lymphocytopenia (<250 cells per cubic millimeter). Ten sex partners, three household contacts, and four children of the patients, as well as six persons who had donated blood to the patients, were immunologically and clinically normal.

Conclusions This investigation of patients with idiopathic CD4+ T-lymphocytopenia and unexplained opportunistic infections indicates that the disorder is rare and represents various clinical and immunologic states. The investigation of contacts revealed no evidence of a new transmissible agent that causes lymphocytopenia.


Source Information

The members of the task force are as follows: Epidemiology and Surveillance Working Group: Martha F. Rogers, M.D. (chair); Epidemiologic Investigations: Scott D. Holmberg, M.D., M.P.H. (coordinator), Thomas J. Spira, M.D., Dawn K. Smith, M.D., M.P.H., M.S., Pascale M. Wortley, M.D., M.P.H., Lisa A. Jackson, M.D. (Division of Bacterial and Mycobacterial Diseases, National Center for Infectious Diseases [NCID]), Judith R. Rudnick, M.D. (Hospital Infections Program, NCID), Judith Falloon, M.D., and Doreen G. Chaitt, R.N., M.P.H. (Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases); Surveillance Operations: I. Celine Hanson, M.D., and John W. Ward, M.D. (coordinators), Joyce J. Neal, Ph.D., M.P.H., Kenneth A. Bell, Laurence Slutsker, M.D., M.P.H., and C. Rene Jones; Other Members: Harold W. Jaffe, M.D., Mark N. Lobato, M.D., Kenneth G. Castro, M.D., Judith A. Hannan, Debra W. Jackson, Bruce L. Evatt, M.D., and Timothy J. Dondero, M.D.; and Laboratory Working Group: Gerald Schochetman, Ph.D. (chair), Charles A. Schable, M.S., J. Steve McDougal, M.D., J. Richard George, Ph.D., Thomas J. Spira, M.D., and Thomas M. Folks, Ph.D.

Address reprint requests to Dr. Smith at the Division of HIV/AIDS, Mailstop E-45, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333.

Full Text of this Article


Related Letters:

CD4+ T-Lymphocytopenia without HIV Infection
Sheppard H., Winkelstein W., Lang W., Charlebois E., Heymann D. L., Belsey E., Esparza J. G., Laurence J., Corboy J. R., Stevens S. R., Griffiths T. W., Cooper K. D., Smith D. K., Neal J. J., Holmberg S. D.
Extract | Full Text  
N Engl J Med 1993; 328:1847-1850, Jun 24, 1993. Correspondence

Idiopathic CD4+ T-Lymphocytopenia
DeHovitz J. A., Feldman J., Landesman S.
Extract | Full Text  
N Engl J Med 1993; 329:1045-1046, Sep 30, 1993. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.